Inhibikase Therapeutics, Inc. IKT
Set alert
1.54 USD -0.01 -0.65%
At close · Nov 2
1.54 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.47 Day range 1.59
1.39 52-week range 2.61
- YTD
- -24.88%
- 1 year
- +4.76%
- Open
- 1.56
- Prev close
- 1.55
- Mkt cap
- 214.89M
- Vol
- 449.23K
- Avg vol
- 574.58K
- EPS
- -0.43
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.47
- High
- 1.59
- Forward P/E
- -11.84
- Beta
- 1.12
- Short ratio
- 0.17
- Inst. own
- 11.62%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 2.62
- 200-d avg
- 1.84
- 1y target
- 7.00
5D chart
Signals (47)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 10:15 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 9:40 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 22 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 22 hours ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:00 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:45 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:35 AM | 3 days ago |
| RSI: Oversold | Oct 30, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 3:15 PM | 4 days ago |
Newest 20 of 47.
Analyst view
Consensus: none
Price target (mean) 7.00 +354.5% upside
Now 1.54
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | -100.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Jefferies | Initiated | — | Buy |
| Oct 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 30, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |